Research graph
References from The predictive value of preoperative ultrasound contrast parameters for early recurrence after transarterial chemoembolization for hepatocellular carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
LARP3 inhibits the apoptosis of hepatocellular carcinoma via the ROS/PI3K/c-Fos axis.
10.1371/journal.pone.0317454 · 2025 · External reference
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.
10.1097/cm9.0000000000002108 · 2022 · External reference
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020.
10.1097/cm9.0000000000001474 · 2021 · External reference
The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global burden of disease study 2016 and implications for liver cancer prevention.
10.1016/j.jhep.2018.12.001 · 2019 · External reference
Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma.
10.3390/ijms21218165 · 2020 · External reference
Risk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolization.
10.3748/wjg.v20.i22.6995 · 2014 · External reference
Guidelines and good clinical practice recommendations for Contrast-enhanced ultrasound (CEUS) in the liver-update 2020 WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS.
10.1016/j.ultrasmedbio.2020.04.030 · 2020 · External reference
Tips and tricks in Contrast-enhanced ultrasound (CEUS) for the characterization and detection of liver malignancies.
10.1055/a-0900-3962 · 2019 · External reference
Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies.
10.1007/s00261-021-03059-y · 2021 · External reference
Value of perfusion parameters for differentiating hepatocellular carcinoma and liver metastasis with hypervascularity and a normal hepatic background on contrast-enhanced ultrasound imaging.
10.1002/jum.14957 · 2019 · External reference
Role of portal vein tumor thrombosis in quantitative perfusion analysis of contrast-enhanced ultrasound of hepatocellular carcinoma.
10.1016/j.ultrasmedbio.2014.12.012 · 2015 · External reference
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights.
10.21037/hbsn-22-469 · 2023 · External reference
Radiomic features at contrast-enhanced CT predict recurrence in early stage hepatocellular carcinoma: a multi-institutional study.
10.1148/radiol.2020191470 · 2020 · External reference
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma.
10.1186/s12943-024-02101-z · 2024 · External reference
Conversion therapy and maintenance therapy for primary hepatocellular carcinoma.
10.5582/bst.2021.01091 · 2021 · External reference
Efficacy of Transarterial chemoembolization (TACE) for early-stage hepatocellular carcinoma.
10.3390/medicina59122174 · 2023 · External reference
Role of CA 19.9 and CEA in predicting diagnosis in hepatocellular carcinoma.
10.4103/jcrt.jcrt_1280_21 · 2023 · External reference
CEUS in prediction of early recurrence of hepatocellular carcinoma after curative resection and to stratify the risk of early recurrence: a retrospective observational study.
10.1007/s00261-024-04252-5 · 2024 · External reference
The value of CEUS LI-RADS combined with AFP in early diagnosis of hepatocellular carcinoma in low- and high-risk patients.
10.4103/jcrt.jcrt_125_24 · 2024 · External reference
Hemodynamic changes during balloon-occluded transarterial chemoembolization (B-TACE) of hepatocellular carcinoma observed by contrast-enhanced ultrasound.
10.1007/s10396-013-0487-7 · 2014 · External reference
Efficacy of endostar combined with transcatheter arterial chemoembolization and analysis of vascular endothelial factor and C-reactive protein levels in patients with advanced hepatocellular carcinoma under contrast enhanced ultrasound.
2019 · External reference
Clinical application of dynamic contrast enhanced ultrasound in monitoring the treatment response of chemoradiotherapy of pancreatic ductal adenocarcinoma.
10.3233/ch-190786 · 2020 · External reference
Percutaneous treatment of malignant liver lesions: evaluation of success using Contrast- enhanced ultrasound (CEUS) and perfusion software.
10.1055/s-0043-119353 · 2018 · External reference
Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging.
10.7863/jum.2003.22.9.911 · 2003 · External reference
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation.
10.1016/j.jhep.2023.08.020 · 2023 · External reference
Higher tumor protein kinase D1 correlates with increased tumor size, BCLC stage, CA199 level, AFP level and worse overall survival in hepatocellular carcinoma patients.
10.1016/j.clinre.2020.11.004 · 2021 · External reference
Combined preoperative albumin-bilirubin (ALBI) and serum γ-glutamyl transpeptidase (GGT) predicts the outcome of hepatocellular carcinoma patients following hepatic resection.
10.7150/jca.33877 · 2019 · External reference
